Tokyo Ohka Kogyo Co., Ltd.TSE: 4186

Consolidated Financial Results for the Fiscal Year Ended December 31, 2025(416.47 KB)

· Issued by Tokyo Ohka Kogyo Co., Ltd.
Consolidated Financial Results for the Fiscal Year Ended December 31, 2025 [J-GAAP]

February 9, 2026 Company name: Tokyo Ohka Kogyo Co., Ltd. Listing: Tokyo Stock Exchange (Prime Market) Securities Code: 4186 URL: https://www.tok.co.jp/eng

Representative: Noriaki Taneichi, President and Chief Executive Officer

Inquiries: Daisuke Matsuyama, General Manager, Accounting Department TEL: +81-44-435-3000 Scheduled date of ordinary general meeting of shareholders: March 27, 2026

Scheduled date to commence dividend payments: March 30, 2026 Scheduled date to file annual securities report: March 24, 2026 Preparation of supplementary material on financial results: Yes

Holding of financial results briefing: Yes (for institutional investors and analysts)

(Yen amounts are rounded down to millions, unless otherwise noted.)

  1. Consolidated Financial Results for the Fiscal Year Ended December 31, 2025 (January 1, 2025 toDecember 31, 2025)
    1. Consolidated Operating Results (% indicates the rate of increase/decrease year-on-year.)

      Net sales

      Operating income

      Ordinary income

      Profit attributable to owners of parent

      Fiscal year ended

      Millions of yen

      %

      Millions of yen

      %

      Millions of yen

      %

      Millions of yen

      %

      December 31, 2025

      237,029

      17.9

      47,386

      43.2

      49,274

      42.6

      33,345

      47.0

      December 31, 2024

      200,966

      23.8

      33,090

      45.7

      34,554

      42.4

      22,683

      78.4

      (Note) Comprehensive income: FY2025: ¥41,830 million [25.8%] FY2024: ¥33,259 million [37.3%]

      Basic earnings per share

      Diluted earnings per share

      Return on equity

      Ratio of ordinary income to total assets

      Operating margin

      Fiscal year ended

      Yen

      Yen

      %

      %

      %

      December 31, 2025

      278.42

      278.21

      15.6

      16.0

      20.0

      December 31, 2024

      187.29

      187.10

      11.8

      12.9

      16.5

      (Reference) Share of profit (loss) of investments accounted for using equity method : FY2025: ¥471 million FY2024: ¥(116) million

    2. Consolidated Financial Position

      Total assets

      Net assets

      Equity ratio

      Net assets per share

      As of

      Millions of yen

      Millions of yen

      %

      Yen

      December 31, 2025

      335,292

      242,299

      67.9

      1,898.90

      December 31, 2024

      281,930

      213,473

      71.1

      1,671.82

      (Reference) Equity: As of December 31, 2025: ¥227,636 million As of December 31, 2024: ¥200,533 million

    3. Consolidated Cash Flows

    Cash flows from operating activities

    Cash flows from investing activities

    Cash flows from financing activities

    Cash and cash equivalents at end of period

    Fiscal year ended

    Millions of yen

    Millions of yen

    Millions of yen

    Millions of yen

    December 31, 2025

    35,194

    (25,291)

    3,172

    69,228

    December 31, 2024

    30,146

    (2,733)

    (15,424)

    56,361

  2. Cash Dividends

    Annual dividends per share

    Total cash dividends

    Payout ratio

    Dividend on equity ratio

    1stquarter

    2nd quarter

    3rd quarter

    Year-end

    Total

    Fiscal year ended

    Yen

    Yen

    Yen

    Yen

    Yen

    Millions of yen

    %

    %

    December 31, 2024

    —

    29.00

    —

    34.00

    63.00

    7,599

    33.5

    4.0

    December 31, 2025

    —

    35.00

    —

    37.00

    72.00

    8,631

    25.9

    4.0

    FY2026 (Forecast)

    —

    40.00

    —

    40.00

    80.00

    27.4

  3. Consolidated Financial Results Forecast for the Fiscal Year Ending December 31, 2026 (January 1, 2026 to December 31, 2026) (% indicates the rate of increase/decrease against the same period of the previous year.)

Net sales

Operating income

Ordinary income

Profit attributable to

owners of parent

Basic earnings

per share

Millions of yen

%

Millions of yen

%

Millions of yen

%

Millions of yen

%

Yen

First half

125,000

12.0

24,300

22.4

25,500

25.1

16,000

17.5

133.47

Full year

261,000

10.1

52,200

10.2

53,800

9.2

35,000

5.0

291.62

* Notes
  1. Significant changes in the scope of consolidation during the period: None

  2. Changes in accounting policies, changes in accounting estimates, and restatement

    1. Changes in accounting policies due to revisions to accounting standards and other regulations: None

    2. Changes in accounting policies due to other reasons: None

    3. Changes in accounting estimates: None

    4. Restatement: None

  3. Number of issued shares (common shares)

    1. Total number of issued shares at the end of the period (including treasury shares)

      As of December 31, 2025

      127,800,000 shares

      As of December 31, 2024

      127,800,000 shares

    2. Number of treasury shares at the end of the period

      As of December 31, 2025

      7,922,099 shares

      As of December 31, 2024

      7,851,327 shares

    3. Average number of shares outstanding during the period

Fiscal year ended December 31, 2025

119,763,425 shares

Fiscal year ended December 31, 2024

121,108,160 shares

(Reference) Overview of Non-Consolidated Financial Results

Non-Consolidated Financial Results for the Fiscal Year Ended December 31, 2025 (from January 1, 2025 to December 31, 2025)
  1. Non-Consolidated Operating Results (% indicates year-on-year changes.)

    Net sales

    Operating income

    Ordinary income

    Profit

    Fiscal year ended

    Millions of yen

    %

    Millions of yen

    %

    Millions of yen

    %

    Millions of yen

    %

    December 31, 2025

    128,009

    12.6

    21,677

    42.7

    32,256

    30.7

    27,556

    31.3

    December 31, 2024

    113,707

    24.5

    15,189

    79.5

    24,686

    85.1

    20,987

    103.8

    Basic earnings

    per share

    Diluted earnings

    per share

    Fiscal year ended

    Yen

    Yen

    December 31, 2025

    230.09

    229.91

    December 31, 2024

    173.29

    173.11

  2. Non-Consolidated Financial Position

Total assets

Net assets

Equity ratio

Net assets per share

As of

Millions of yen

Millions of yen

%

Yen

December 31, 2025

237,803

175,628

73.8

1,464.39

December 31, 2024

196,093

154,907

78.9

1,290.43

(Reference) Equity: As of December 31, 2025: ¥175,548 million As of December 31, 2024: ¥154,786 million

  • The Financial Results report is outside the scope of an audit by certified public accountants or an audit firm.

  • Explanation of the proper use of financial results forecast and other special notes

The financial results forecast stated in this report are based on the information available as of the date of the release of this report, and actual results may differ from the forecast due to a variety of factors.

Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.

○Table of contents of the attached document

  1. Overview of Operating Results, Etc 2

    1. Overview of Operating Results for the Fiscal Year Ended December 31, 2025 2

    2. Overview of Financial Position as of December 31, 2025 2

    3. Overview of Cash Flows for the Fiscal Year Ended December 31, 2025 3

    4. Future Outlook 3

  2. Basic Policy for Selection of Accounting Standards 4

  3. Consolidated Financial Statements and Major Notes 5

    1. Consolidated Balance Sheet 5

    2. Consolidated Statement of Income and Consolidated Statement of Comprehensive Income 7

      Consolidated Statement of Income 7

      Consolidated Statement of Comprehensive Income 8

    3. Consolidated Statement of Changes in Equity 9

    4. Consolidated Statement of Cash Flows 11

    5. Notes to Consolidated Financial Statements 13

(Notes Concerning Going Concern Assumption) 13

(Notes Concerning Consolidated Statement of Income) 13

(Notes Concerning Consolidated Statement of Cash Flows) 14

(Notes Concerning Segment Information, Etc.) 14

(Per Share Information) 15

  1. Overview of Operating Results, Etc.
    1. Overview of Operating Results for the Fiscal Year Ended December 31, 2025
      1. Operating results for the fiscal year ended December 31, 2025

        For the fiscal year ended December 31, 2025, the electronics market, which is the main customers for the Group’s products, saw steady growth in demand for generative AI-related products and for PCs backed by replacement trends while smartphone demand remained soft.

        Amid such circumstances, the Group, with an aim to gain No.1 global market share of cutting-edge photoresists, has continued to pursue a thorough customer perspective. We also promoted strategic investments in anticipation of future growth in semiconductor demand, including the construction of a new photoresist manufacturing building in Koriyama Plant in Japan, while overseas, a new inspection building in Incheon, South Korea, was completed and construction of a new high-purity chemical manufacturing building was commenced at a site purchased in Pyeongtaek.

        In addition, as part of our all-out effort to attain our long-term vision, “tok Vision 2030,” we made micro resist technology GmbH in Germany our wholly-owned subsidiary to strengthen our customer-oriented strategy in the European market and enhance our product portfolio by integrating the company’s technologies.

        As a result, sales of both electronic functional materials and high-purity chemicals increased significantly, and for the fiscal year ended December 31, 2025, the Group posted net sales of ¥237,029 million (up 17.9% year-on-year). Also, driven primarily by higher sales of high value-added products and a one-off profit recorded in connection with the recognition of inventories such as development-related materials, the Group recorded operating income of ¥47,386 million (up 43.2% year-on-year) and ordinary income of ¥49,274 million (up 42.6% year-on-year). Profit attributable to owners of parent increased to ¥33,345 million (up 47.0% year-on-year) due to higher operating income and the recording of extraordinary income associated with the transfer of Equipment Business, and both net sales and profit have hit a record high.

        Operating results by business segment are not disclosed, but net sales by division are as follows.

        Net sales in the Electronic Functional Materials Division amounted to ¥124,700 million (up 16.0% year-on-year), net sales in the High-Purity Chemicals Division amounted to ¥109,400 million (up 19.6% year-on-year), and net sales in Other amounted to ¥2,928 million (up 48.3% year-on-year).

    2. Overview of Financial Position as of December 31, 2025

      (Assets)

      Total assets as of December 31, 2025 increased by ¥53,362 million from December 31, 2024 to ¥335,292 million.

      Total current assets increased by ¥21,003 million from December 31, 2024 to ¥172,773 million mainly due to increases in cash and deposit of ¥11,915 million and in accounts receivable - trade of ¥5,321 million.

      Total non-current assets increased by ¥32,358 million from December 31, 2024 to ¥162,518 million mainly due to an increase of ¥20,251 million in property, plant and equipment associated with capital investments. (Liabilities)

      Total liabilities as of December 31, 2025 increased by ¥24,536 million from December 31, 2024 to ¥92,993 million mainly due to increases in bonds payable of ¥10,000 million and in long-term borrowings of ¥10,000 million.

      (Net assets)

      Total net assets as of December 31, 2025 increased by ¥28,826 million from December 31, 2024 to ¥242,299 million mainly due to increases in retained earnings of ¥25,071 million and in valuation difference on available-for-sale securities of ¥1,982 million.

      As a result, the equity ratio as of December 31, 2025 stood at 67.9%.

    3. Overview of Cash Flows for the Fiscal Year Ended December 31, 2025

      (Cash flows from operating activities)

      Net cash provided by operating activities during the fiscal year ended December 31, 2025 increased by ¥5,048 million from a year earlier to ¥35,194 million mainly because cash inflow increased due to an increase in profit before income taxes despite an increase in income taxes paid.

      (Cash flows from investing activities)

      Net cash used in investing activities increased by ¥22,558 million from a year earlier to ¥25,291 million mainly because cash outflow increased due to purchase of property, plant and equipment.

      (Cash flows from financing activities)

      Net cash provided by financing activities was ¥3,172 million because cash inflow increased by ¥18,597 million from a year earlier mainly due to proceeds from long-term borrowings and proceeds from issuance of bonds.

      As a result, cash and cash equivalents increased by ¥12,867 million from December 31, 2024 to ¥69,228 million.

      (Reference) Cash flow indicators

      FY2021

      FY2022

      FY2023

      FY2024

      FY2025

      Equity ratio (%)

      71.7

      71.3

      72.9

      71.1

      67.9

      Equity ratio at market value (%)

      125.7

      101.3

      149.6

      150.3

      207.6

      Interest-bearing debt to cash flow ratio (%)

      58.4

      59.2

      64.5

      36.8

      77.1

      Interest coverage ratio (times)

      272.3

      258.8

      210.1

      348.4

      208.8

      Equity ratio: Equity/Total assets

      Equity ratio at market value: Market capitalization/Total assets

      Interest-bearing debt to cash flow ratio: Interest-bearing debt/Cash flow Interest coverage ratio: Cash flow/Interest payment

      (Note 1) All ratios are calculated based on the financial figures on a consolidated basis.

      (Note 2) Market capitalization is calculated based on the number of shares issued and outstanding excluding treasury shares.

      (Note 3) Cash flow is derived from cash flows from operating activities.

      (Note 4) Interest-bearing debt includes all liabilities recorded on the consolidated balance sheet that are subject to interest payment.

    4. Future Outlook

      For FY2026, with the continued strong demand in the electronics market for generative AI-related products, particularly for data centers, we expect a significant year-on-year increase in both revenue and profit based on the anticipated growth in materials for advanced semiconductors, the usage status of the Group’s products, and the launch of operations of customers’ new plants.

      In FY2026, toward the realization of tok Vision 2030 to become “The e-Material Global CompanyTM” contributing to a sustainable future through chemistry, the Group will accelerate the growth under “tok Medium-Term Plan 2027” launched in FY2025 by further promoting “Gain No.1 global market share of cutting-edge photoresists,” “Increase global share in all business fields with an eye on tok Vision 2030,” “Create businesses in new fields,” “Secure stable supplies of high-quality products,” “Improve employee engagement,” and “Establish a robust management foundation to realize tok Vision 2030.”

      The foreign exchange rate is assumed to be $1= ¥150.

      (Millions of yen, %)

      Fiscal year ended December 31, 2025 (Results)

      Fiscal year ending December 31, 2026

      (Forecast)

      Year-on-year

      Net sales

      237,029

      261,000

      10.1

      Operating income

      47,386

      52,200

      10.2

      Ordinary income

      49,274

      53,800

      9.2

      Profit attributable to owners of parent

      33,345

      35,000

      5.0

  2. Basic Policy for Selection of Accounting Standards

    The Group has adopted Japanese GAAP.

    The Group is currently examining the potential application of International Financial Reporting Standards (IFRS) in light of the trend in convergence of Japanese GAAP and revisions to IFRS by taking into account the impact of the transition to IFRS and the response thereto on the management.

  3. Consolidated Financial Statements and Major Notes
    1. Consolidated Balance Sheet

      (Millions of yen)

      FY12/24

      (As of December 31, 2024)

      FY12/25

      (As of December 31, 2025)

      Assets

      Current assets

      Cash and deposits

      59,047

      70,962

      Notes receivable - trade

      1,001

      1,479

      Accounts receivable - trade

      41,845

      47,166

      Securities

      3,999

      —

      Merchandise and finished goods

      12,602

      14,910

      Work in process

      9,539

      10,849

      Raw materials and supplies

      14,744

      18,246

      Other

      9,079

      9,248

      Allowance for doubtful accounts

      (90)

      (90)

      Total current assets

      151,770

      172,773

      Non-current assets

      Property, plant and equipment

      Buildings and structures

      92,964

      98,853

      Accumulated depreciation

      (52,696)

      (55,469)

      Buildings and structures, net

      40,267

      43,383

      Machinery, equipment and vehicles

      70,271

      76,212

      Accumulated depreciation

      (61,680)

      (64,487)

      Machinery, equipment and vehicles, net

      8,591

      11,724

      Tools, furniture and fixtures

      28,949

      32,636

      Accumulated depreciation

      (21,959)

      (24,092)

      Tools, furniture and fixtures, net

      6,989

      8,543

      Right-of-use assets

      915

      1,025

      Accumulated depreciation

      (480)

      (498)

      Right-of-use assets, net

      434

      527

      Land

      10,890

      13,989

      Construction in progress

      22,769

      32,025

      Total property, plant and equipment

      89,942

      110,193

      Intangible assets

      1,811

      1,834

      Investments and other assets

      Investment securities

      22,146

      31,912

      Investments in capital

      84

      81

      Long-term loans receivable

      34

      61

      Retirement benefit asset

      9,404

      10,083

      Deferred tax assets

      1,333

      1,635

      Other

      5,408

      6,715

      Allowance for doubtful accounts

      (5)

      —

      Total investments and other assets

      38,406

      50,490

      Total non-current assets

      130,160

      162,518

      Total assets

      281,930

      335,292

      (Millions of yen)

      FY12/24

      (As of December 31, 2024)

      FY12/25

      (As of December 31, 2025)

      Liabilities

      Current liabilities

      Notes and accounts payable - trade

      26,869

      29,544

      Short-term borrowings

      4,442

      383

      Accounts payable - other

      7,929

      11,015

      Income taxes payable

      5,020

      6,863

      Advances received

      150

      242

      Provision for bonuses

      3,479

      4,575

      Provision for bonuses for directors (and other officers)

      501

      304

      Other

      5,709

      6,443

      Total current liabilities

      54,104

      59,373

      Non-current liabilities

      Bonds payable

      —

      10,000

      Long-term borrowings

      6,100

      16,100

      Deferred tax liabilities

      5,021

      5,082

      Retirement benefit liability

      280

      359

      Asset retirement obligations

      82

      69

      Other

      2,868

      2,007

      Total non-current liabilities

      14,352

      33,619

      Total liabilities

      68,456

      92,993

      Net assets

      Shareholders' equity

      Share capital

      14,640

      14,640

      Capital surplus

      15,612

      15,899

      Retained earnings

      159,313

      184,384

      Treasury shares

      (15,796)

      (16,586)

      Total shareholders’ equity

      173,769

      198,337

      Accumulated other comprehensive income

      Valuation difference on available-for-sale

      securities

      9,509

      11,492

      Foreign currency translation adjustment

      13,649

      14,103

      Remeasurements of defined benefit plans

      3,605

      3,703

      Total accumulated other comprehensive

      income

      26,764

      29,299

      Share acquisition rights

      121

      79

      Non-controlling interests

      12,818

      14,583

      Total net assets

      213,473

      242,299

      Total liabilities and net assets

      281,930

      335,292

    2. Consolidated Statement of Income and Consolidated Statement of Comprehensive Income (Consolidated Statement of Income)

      (Millions of yen)

      FY 12/24

      (January 1, 2024 – December 31, 2024)

      FY 12/25

      (January 1, 2025 – December 31, 2025)

      Net sales

      200,966

      237,029

      Cost of sales

      *1,*3127,521

      *1,*3147,588

      Gross profit

      73,444

      89,440

      Selling, general and administrative expenses

      *2,*340,353

      *2,*342,054

      Operating income

      33,090

      47,386

      Non-operating income

      Interest income

      397

      406

      Dividend income

      580

      653

      Share of profit of investments accounted for

      using equity method

      —

      471

      Foreign exchange gains

      —

      289

      Subsidy income

      328

      403

      Other

      589

      540

      Total non-operating income

      1,895

      2,765

      Non-operating expenses

      Interest expenses

      86

      168

      Commission expenses

      24

      230

      Share of loss of investments accounted for using equity method

      116

      —

      Loss on valuation of derivatives

      35

      360

      Foreign exchange losses

      98

      —

      Other

      68

      117

      Total non-operating expenses

      431

      876

      Ordinary income

      34,554

      49,274

      Extraordinary income

      Gain on change in equity

      198

      —

      Gain on sale of non-current assets

      22

      11

      Gain on sale of investment securities

      508

      245

      Gain on receipt of contingent consideration

      —

      *41,422

      Total extraordinary income

      730

      1,679

      Extraordinary losses

      Loss on change in equity

      —

      12

      Impairment losses

      —

      283

      Loss on retirement of non-current assets

      122

      364

      Other

      4

      0

      Total extraordinary losses

      126

      661

      Profit before income taxes

      35,158

      50,292

      Income taxes - current

      8,343

      12,291

      Income taxes - deferred

      (237)

      (1,187)

      Total income taxes

      8,105

      11,104

      Profit

      27,052

      39,188

      Profit attributable to non-controlling interests

      4,369

      5,843

      Profit attributable to owners of parent

      22,683

      33,345

      (Consolidated Statement of Comprehensive Income)

      (Millions of yen)

      FY 12/24

      (January 1, 2024 – December 31, 2024)

      FY 12/25

      (January 1, 2025 – December 31, 2025)

      Profit

      27,052

      39,188

      Other comprehensive income

      Valuation difference on available-for-sale

      securities

      (249)

      1,982

      Foreign currency translation adjustment

      2,495

      561

      Remeasurements of defined benefit plans

      3,959

      97

      Total other comprehensive income

      6,206

      2,641

      Comprehensive income

      33,259

      41,830

      Comprehensive income attributable to:

      Owners of parent

      28,440

      35,880

      Non-controlling interests

      4,818

      5,950

    3. Consolidated Statement of Changes in Equity

      For the fiscal year ended December 31, 2024 (January 1, 2024 – December 31, 2024)

      (Millions of yen)

      Shareholders' equity

      Share capital

      Capital surplus

      Retained earnings

      Treasury shares

      Total

      shareholders’

      equity

      Balance at beginning of period

      14,640

      15,315

      143,630

      (10,940)

      162,646

      Changes during period

      Dividends of surplus

      (7,001)

      (7,001)

      Profit attributable to owners of parent

      22,683

      22,683

      Purchase of treasury shares

      (5,507)

      (5,507)

      Disposal of treasury shares

      296

      650

      947

      Net changes in items other than

      shareholders' equity

      Total changes during period

      —

      296

      15,682

      (4,856)

      11,122

      Balance at end of period

      14,640

      15,612

      159,313

      (15,796)

      173,769

      Accumulated other comprehensive income

      Share acquisition rights

      Non-controlling interests

      Total net assets

      Valuation difference on available-for-sale securities

      Foreign currency translation adjustment

      Remeasurements of

      defined benefit plans

      Total accumulated other comprehensive income

      Balance at beginning of period

      9,759

      11,603

      (354)

      21,007

      140

      11,684

      195,480

      Changes during period

      Dividends of surplus

      (7,001)

      Profit attributable to owners of parent

      22,683

      Purchase of treasury shares

      (5,507)

      Disposal of treasury shares

      (19)

      927

      Net changes in items other than

      shareholders' equity

      (249)

      2,046

      3,959

      5,756

      —

      1,133

      6,890

      Total changes during period

      (249)

      2,046

      3,959

      5,756

      (19)

      1,133

      17,993

      Balance at end of period

      9,509

      13,649

      3,605

      26,764

      121

      12,818

      213,473

      For the fiscal year ended December 31, 2025 (January 1, 2025 – December 31, 2025)

      (Millions of yen)

      Shareholders' equity

      Share capital

      Capital surplus

      Retained earnings

      Treasury shares

      Total

      shareholders’

      equity

      Balance at beginning of period

      14,640

      15,612

      159,313

      (15,796)

      173,769

      Changes during period

      Dividends of surplus

      (8,274)

      (8,274)

      Profit attributable to owners of parent

      33,345

      33,345

      Purchase of treasury shares

      (1,502)

      (1,502)

      Disposal of treasury shares

      286

      712

      999

      Net changes in items other than

      shareholders' equity

      Total changes during period

      —

      286

      25,071

      (789)

      24,568

      Balance at end of period

      14,640

      15,899

      184,384

      (16,586)

      198,337

      Accumulated other comprehensive income

      Share acquisition rights

      Non-controlling interests

      Total net assets

      Valuation difference on available-

      for-sale securities

      Foreign currency translation adjustment

      Remeasurements of

      defined benefit plans

      Total accumulated other comprehensive income

      Balance at beginning of period

      9,509

      13,649

      3,605

      26,764

      121

      12,818

      213,473

      Changes during period

      Dividends of surplus

      (8,274)

      Profit attributable to owners of parent

      33,345

      Purchase of treasury shares

      (1,502)

      Disposal of treasury shares

      (42)

      957

      Net changes in items other than shareholders' equity

      1,982

      454

      97

      2,534

      —

      1,765

      4,300

      Total changes during period

      1,982

      454

      97

      2,534

      (42)

      1,765

      28,826

      Balance at end of period

      11,492

      14,103

      3,703

      29,299

      79

      14,583

      242,299

    4. Consolidated Statement of Cash Flows

      (Millions of yen)

      FY 12/24

      (January 1, 2024 – December 31, 2024)

      FY 12/25

      (January 1, 2025 – December 31, 2025)

      Cash flows from operating activities

      Profit before income taxes

      35,158

      50,292

      Depreciation

      8,333

      8,807

      Impairment losses

      —

      283

      Increase (decrease) in allowance for doubtful

      accounts

      14

      (5)

      Increase in provision for bonuses

      930

      1,089

      Increase (decrease) in provision for bonuses for directors (and other officers)

      306

      (197)

      Increase in retirement benefit asset

      (73)

      (331)

      Increase (decrease) in retirement benefit liability

      85

      (76)

      Interest and dividend income

      (977)

      (1,059)

      Interest expenses

      86

      168

      Foreign exchange gains

      (658)

      (364)

      Loss on valuation of derivatives

      35

      360

      Share of loss (profit) of investments accounted for using equity method

      116

      (471)

      Gain on sale of non-current assets

      (22)

      (11)

      Loss on retirement of non-current assets

      122

      364

      Gain on sale of investment securities

      (508)

      (245)

      Gain on receipt of contingent consideration

      —

      (1,422)

      (Gain) loss on change in equity

      (198)

      12

      Increase in trade receivables

      (7,842)

      (5,207)

      Increase in inventories

      (3,115)

      (6,809)

      Increase in trade payables

      5,874

      2,208

      (Decrease) increase in advances received

      (53)

      89

      Other

      (3,970)

      (2,760)

      Subtotal

      33,642

      44,712

      Interest and dividends received

      1,008

      1,105

      Interest paid

      (86)

      (158)

      Income taxes paid

      (4,418)

      (10,465)

      Net cash provided by operating activities

      30,146

      35,194

      Cash flows from investing activities

      Purchase of securities

      (12,000)

      —

      Proceeds from redemption of securities

      12,000

      3,000

      Purchase of property, plant and equipment

      (24,570)

      (24,762)

      Proceeds from sale of property, plant and equipment

      56

      56

      Purchase of intangible assets

      (936)

      (613)

      Purchase of investment securities

      (107)

      (6,672)

      Proceeds from sale of investment securities

      921

      393

      Net decrease in time deposits

      11,516

      2,000

      Proceeds from withdrawal of long-term time

      deposits

      12,000

      —

      Proceeds from settlement of contingent consideration

      —

      1,422

      Other

      (1,614)

      (116)

      Net cash used in investing activities

      (2,733)

      (25,291)

      (Millions of yen)

      FY 12/24

      (January 1, 2024 – December 31, 2024)

      FY 12/25

      (January 1, 2025 – December 31, 2025)

      Cash flows from financing activities

      Proceeds from short-term borrowings

      520

      366

      Repayments of short-term borrowings

      (520)

      (513)

      Proceeds from long-term borrowings

      —

      10,000

      Repayments of long-term borrowings

      —

      (3,900)

      Proceeds from issuance of bonds

      —

      10,000

      Purchase of treasury shares

      (5,520)

      (44)

      Proceeds from sale of treasury shares

      927

      0

      Dividends paid

      (6,996)

      (8,268)

      Dividends paid to non-controlling interests

      (3,685)

      (4,184)

      Other

      (150)

      (282)

      Net cash (used in) provided by financing activities

      (15,424)

      3,272

      Effect of exchange rate change on cash and cash

      equivalents

      1,585

      (208)

      Net increase in cash and cash equivalents

      13,572

      12,867

      Cash and cash equivalents at beginning of period

      42,788

      56,361

      Cash and cash equivalents at end of period

      *56,361

      *69,228

    5. Notes to Consolidated Financial Statements (Notes Concerning Going Concern Assumption)

Not applicable.

(Notes Concerning Consolidated Statement of Income)

*1 Inventories as of December 31 are stated at written-down value to reflect a decline in profitability, and the following loss on valuation of inventories (gain on reversal of loss) is included in cost of sales.

FY12/24

(January 1, 2024 – December 31, 2024)

FY12/25

(January 1, 2025 – December 31, 2025)

Loss on valuation of inventories ¥152 million ¥132 million

*2 Major components and amounts of selling, general and administrative expenses are as follows.

FY12/24

(January 1, 2024 – December 31, 2024)

FY12/25

(January 1, 2025 – December 31, 2025)

Storage and transportation costs

¥4,222 million

¥4,454 million

Salaries and allowances

9,536

10,743

Provision for bonuses

1,837

2,361

Retirement benefit expenses

442

151

Research supplies expense

5,493

5,635

Depreciation

3,187

3,355

*3 R&D costs included in general and administrative expenses and manufacturing costs are as follows.

FY12/24

(January 1, 2024 – December 31, 2024)

FY12/25

(January 1, 2025 – December 31, 2025)

General and administrative expenses

¥14,379 million

¥15,474million

Manufacturing costs

140

199

Total R&D costs

14,519

15,673

*4 Gain on receipt of contingent consideration

A share transfer agreement previously entered into by the Company contained a clause stipulating that additional consideration may be received if certain conditions are met. During the fiscal year ended December 31, 2025, the Company met the conditions and received additional consideration, which was recorded in extraordinary income.

(Notes Concerning Consolidated Statement of Cash Flows)

* Reconciliation between the ending balance of cash and cash equivalents and the balance in the consolidated balance sheet

FY12/24 FY12/25

(January 1, 2024 – December 31, 2024) (January 1, 2025 – December 31, 2025)

Cash and deposits ¥59,047 million ¥70,962 million Securities 999 -

Term deposits with maturities over three

months

(3,686) (1,734)

Cash and cash equivalents 56,361 69,228

(Notes Concerning Segment Information, Etc.)

[Segment Information]

The Group segments its business based on products and services, with each business unit developing the comprehensive strategy on their respective products and services in Japan and overseas and conducting business activities.

The Group engages in manufacturing and sales of mainly electronic functional materials and high-purity chemicals. The disclosure is omitted as the Group operates a single business segment.

[Related Information]

Fiscal year ended December 31, 2024 (January 1, 2024 - December 31, 2024)

  1. Information by product and service

    The disclosure is omitted as the corresponding information is disclosed in Segment Information.

  2. Information by geographic region

(1) Net sales

(Millions of yen)

Japan

Taiwan

South Korea

The U.S.

China

Other

Total

32,539

68,623

26,314

19,567

42,770

11,150

200,966

Fiscal year ended December 31, 2025 (January 1, 2025 - December 31, 2025)

  1. Information by product and service

    The disclosure is omitted as the corresponding information is disclosed in Segment Information.

  2. Information by geographic region

(1) Net sales

(Millions of yen)

Japan

Taiwan

South Korea

The U.S.

China

Other

Total

36,638

85,604

30,447

24,019

48,611

11,708

237,029

(Per Share Information)

FY12/24

(January 1,2024–December 31,2024)

FY12/25

(January 1,2025–December 31,2025)

Net assets per share

¥1,671.82

¥1,898.90

Basic earnings per share

¥187.29

¥278.42

Diluted earnings per share

¥187.10

¥278.21

(Notes) 1. Basis for calculation of net assets per share is as follows.

FY12/24

(As of December 31, 2024)

FY12/25

(As of December 31, 2025)

Total net assets (millions of yen)

213,473

242,299

Amount deducted from net assets (millions of yen)

12,939

14,662

(of which, share acquisition rights) (millions of yen)

(121)

(79)

(of which non-controlling interest) (millions of yen)

(12,818)

(14,583)

Net assets as of year-end related to common shares

(millions of yen)

200,533

227,636

Number of common shares issued and outstanding

(thousand shares)

127,800

127,800

Number of treasury shares out of common shares

(thousand shares)

7,851

7,922

Number of common shares at year-end used to

calculate net assets per share (thousand shares)

119,948

119,877

2. Basis for calculation of basic and diluted earnings per share is as follows.

FY12/24

(January 1,2024–December 31,2024)

FY12/25

(January 1,2025–December 31,2025)

(1) Basic earnings per share

Profit attributable to owners of parent (millions of

yen)

22,683

33,345

Amount not attributable to common shareholders (millions of yen)

—

—

Profit attributable to owners of parent related to

common shares (millions of yen)

22,683

33,345

Average number of common shares during the

period (thousand shares)

121,108

119,763

(2) Diluted earnings per share

Adjustment to profit attributable to owners of parent

(millions of yen)

—

—

Increase in number of common shares (thousand shares)

126

92

(of which, share acquisition rights) (thousand shares)

(126)

(92)

Dilutive shares not included in the calculation of diluted earnings per share because of their anti-dilutive effect

—

—

(Note) The Company’s shares owned by “Tokyo Ohka Employees Stockholding Association Trust” are included in treasury shares which is excluded in the calculation of the average number of shares during the period to calculate “Basic earnings per share” and “Diluted earnings per share.” (211 thousand shares and - thousand share for the fiscal years ended December 31, 2024 and 2025, respectively).

Earlier from Tokyo Ohka Kogyo

All Tokyo Ohka Kogyo news releases